Andrew C. Von Eschenbach is Director of Celularity Inc. Currently has a direct ownership of 336,066 shares of CELU, which is worth approximately $719,181. The most recent transaction as insider was on Jun 14, 2023, when has been sold 199,921 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 336K
0% 3M change
0% 12M change
Total Value Held $719,181

ANDREW C. VON ESCHENBACH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Grant, award, or other acquisition
-
199,921 Added 37.3%
336,066 Class A Common Stock
Jul 13 2022
BUY
Grant, award, or other acquisition
-
36,145 Added 20.98%
136,145 Class A Common Stock
Nov 09 2021
BUY
Exercise of conversion of derivative security
$28,000 $0.28 p/Share
100,000 Added 50.0%
100,000 Class A Common Stock

Also insider at

RDUS
Radius Health, Inc. Healthcare
BHC
Bausch Health Companies Inc. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
MTACW
MedTech Acquisition Corp
ACV

Andrew C. Von Eschenbach

Director
Florham Park, NJ

Track Institutional and Insider Activities on CELU

Follow Celularity Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CELU shares.

Notify only if

Insider Trading

Get notified when an Celularity Inc insider buys or sells CELU shares.

Notify only if

News

Receive news related to Celularity Inc

Track Activities on CELU